S100A8 and chronic myelogenous leukemia, BCR-ABL1 positive: Since CML-modified S100A8 und S100 A8/9 were detected in inflamed gut tissue, it can be speculated that CML-modifications further enhance the binding of these natural ligands of RAGE [19].